{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T21:11:22Z","timestamp":1776028282412,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ejogrb.2006.02.015","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T13:42:46Z","timestamp":1145454166000},"page":"157-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Severe hypertension in pregnancy: Hydralazine or labetalol"],"prefix":"10.1016","volume":"128","author":[{"given":"Paulino","family":"Vigil-De Gracia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Lasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Vega-Malek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flor Tem","family":"de Mena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2006.02.015_bib1","doi-asserted-by":"crossref","unstructured":"ACOG. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;99:159\u201367.","DOI":"10.1097\/00006250-200201000-00028"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib2","doi-asserted-by":"crossref","unstructured":"Report of the national high blood pressure education program. Working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1\u201322.","DOI":"10.1067\/mob.2000.107928"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib3","series-title":"Williams obstetrics","article-title":"Hypertensive disorders in pregnancy","author":"Cunningham","year":"2001"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1471-0528.1992.tb13818.x","article-title":"Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean","volume":"99","author":"Duley","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib5","first-page":"1245","article-title":"Report of the Canadian hypertension society consensus conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy","volume":"157","author":"Rey","year":"1997","journal-title":"CMAJ"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0301-2115(00)00383-3","article-title":"Management and monitoring of severe preeclampsia","volume":"96","author":"Bolte","year":"2001","journal-title":"Eur J Obstet Gynecol Rep Biol"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","article-title":"Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis","volume":"327","author":"Magee","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-3476(95)70277-6","article-title":"Use of glucagons to treat neonatal low-output congestive heart failure after maternal labetalol therapy","volume":"127","author":"Stevens","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJM199803053381009","article-title":"Calcium-channel blockers for hypertension\u2014uncertainty continues","volume":"338","author":"Cutler","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib10","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/jama.1996.03540160050032","article-title":"Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?","volume":"276","author":"Crossman","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib11","first-page":"2","article-title":"Drugs for rapid treatment of very high blood pressure during pregnancy","author":"Duley","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00001703-200312000-00006","article-title":"Post magpie: how should we be managing severe preeclampsia?","volume":"15","author":"Frias","year":"2003","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib13","first-page":"328","article-title":"A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy","volume":"70","author":"Mabie","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib14","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.HYP.17.6.1072","article-title":"Central hemodynamic observations in untreated preeclamptic patients","volume":"17","author":"Visser","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0301-2115(01)00611-X","article-title":"The optimal dosage of ketanserin for patients with severe hypertension in pregnancy","volume":"102","author":"Van Schie","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.1991.tb10339.x","article-title":"Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol","volume":"98","author":"Harper","year":"1991","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib17","first-page":"354","article-title":"Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy","volume":"71","author":"Ashe","year":"1987","journal-title":"S Afr Med J"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib18","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/0002-9378(93)90383-T","article-title":"Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine","volume":"168","author":"Bhorat","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib19","first-page":"183","article-title":"Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy","volume":"1","author":"Garden","year":"1982","journal-title":"Clin Exp Hypertens B"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib20","first-page":"181","article-title":"Diagnosis and management of gestational hypertension and preeclampsia","volume":"102","author":"Sibai","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0301-2115(02)00269-5","article-title":"Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks\u2019 gestation","volume":"107","author":"Vigil-De Gracia","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1081\/PRG-200030315","article-title":"Pregnancy and severe chronic hypertension: maternal outcome","volume":"23","author":"Vigil-De Gracia","year":"2004","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00003081-200203000-00013","article-title":"Pharmacologic therapy for peripartum emergencies","volume":"45","author":"Berg","year":"2002","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib24","first-page":"331","article-title":"Nifedipine in the treatment of severe preeclampsia","volume":"77","author":"Fenakel","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2006.02.015_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1600-0412.2002.810105.x","article-title":"Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia","volume":"81","author":"Aali","year":"2002","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211506001485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211506001485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:15:55Z","timestamp":1759554955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211506001485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":25,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0301211506001485"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2006.02.015","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe hypertension in pregnancy: Hydralazine or labetalol","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2006.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}